Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

agilon health Reports Second Quarter 2026 Results

$AGLPress releaseAug 5, 2026, 4:05 PM ETRead the release

agilon health posted Q2 revenue of $1.49 billion, up 7% year-over-year, driven by favorable medical cost trends and improved pricing despite a 10% decline in total membership. The company achieved a significant operational turnaround, reporting net income of $18 million versus a net loss of $104 million in the prior year, with Adjusted EBITDA swinging to a positive $70 million.

Key figures

Eps
1.07
Revenue
1495000000
Guidance
FY26 revenue $5.775B-$5.86B (raised from $5.68B-$5.805B); Adjusted EBITDA $75M-$95M (raised from $10M-$40M)
Revenue Yoy
7%
Total members
549000
Medical margin
197000000
Adjusted ebitda
70000000
Medicare advantage members
437000

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    AGL: agilon health Reports Second Quarter 2026 Results — AI Analysis | Signal8